Vice President of Waters Sells 26,500 Shares
News May 20, 2015
Waters VP Mark T. Beaudouin sold 26,500 shares of Waters stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $133.00, for a total value of $3,524,500.00. Following the sale, the vice president now directly owns 9,129 shares of the company’s stock, valued at approximately $1,214,157.
Waters has been the subject of a number of recent research reports. Analysts at Cantor Fitzgerald raised their price target on shares of Waters from $133.00 to $140.00 and gave the company a “buy” rating in a research note on Wednesday, April 29th. Analysts at Maxim Group raised their price target on shares of Waters from $145.00 to $158.00 and gave the company a “buy” rating in a research note on Wednesday, April 29th. Finally, analysts at Zacks reiterated a “hold” rating and set a $126.00 price target on shares of Waters in a research note on Tuesday, March 24th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $123.00.
Waters opened at 133.19 on Wednesday. Waters has a 52-week low of $93.56 and a 52-week high of $133.91. The stock’s 50-day moving average is $126, and its 200-day moving average is $119.The company has a market cap of $11.01 billion and a P/E ratio of 24.63.
Waters last issued its quarterly earnings data on Tuesday, April 28th. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.19. The company had revenue of $460.00 million for the quarter, compared to the consensus estimate of $444.30 million. During the same quarter in the previous year, the company posted $0.92 earnings per share. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. On average, analysts predict that Waters will post $5.78 earnings per share for the current fiscal year.
Waters Corporation is an analytical instrument manufacturer that primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (NYSE:WAT), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE
Blood Donors' Leftover Immune Cells Reveal Secrets of Antibody AffinityNews
During some kinds of blood donations, such as platelet donation, you get most of the blood back. Researchers have been able to use leftover blood donor cells to gain crucial insights into how natural killer cells circulating in the human body differ from those typically studied in the lab.READ MORE
Why People Experience Seasonal Skin ChangesNews
A study provides information that may help explain why many people experience eczema and dry skin in the winter. In tests of skin on 80 adults, the levels of breakdown products of filaggrin—a protein that helps maintain the skin’s barrier function—changed between winter and summer on the cheeks and hands.READ MORE